These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

890 related items for PubMed ID: 9591858

  • 21. [Second carcinomas in cancers of the mouth cavity, pharynx and larynx. Clinical, histopathologic and cell kinetic findings].
    Esser D, Anke S, Roessner A, Freigang B.
    Laryngorhinootologie; 2000 Aug; 79(8):478-82. PubMed ID: 11006912
    [Abstract] [Full Text] [Related]

  • 22. The level of cervical lymph node metastases: their prognostic relevance and relationship with head and neck squamous carcinoma primary sites.
    Jones AS, Roland NJ, Field JK, Phillips DE.
    Clin Otolaryngol Allied Sci; 1994 Feb; 19(1):63-9. PubMed ID: 8174305
    [Abstract] [Full Text] [Related]

  • 23. Tumor-related markers in histologically normal margins correlate with locally recurrent oral squamous cell carcinoma: a retrospective study.
    Wang X, Chen S, Chen X, Zhang C, Liang X.
    J Oral Pathol Med; 2016 Feb; 45(2):83-8. PubMed ID: 26260282
    [Abstract] [Full Text] [Related]

  • 24. Assessing immuno-expression of p53 protein and TP 53 gene amplification in histologically negative surgical margins of oral squamous cell carcinoma patients and normal oral mucosa.
    Kamat MS, Puranik RS, Das Rai AB, Patil BR, Patil S.
    Clin Oral Investig; 2022 Oct; 26(10):6235-6243. PubMed ID: 35674840
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Differences in expression of oncogenes and tumor suppressor genes in different sites of head and neck squamous cell.
    Takes RP, Baatenburg de Jong RJ, Schuuring E, Litvinov SV, Hermans J, Van Krieken JH.
    Anticancer Res; 1998 Oct; 18(6B):4793-800. PubMed ID: 9891559
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. p53 and Ki-67 as markers of radioresistance in head and neck carcinoma.
    Couture C, Raybaud-Diogène H, Têtu B, Bairati I, Murry D, Allard J, Fortin A.
    Cancer; 2002 Feb 01; 94(3):713-22. PubMed ID: 11857304
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. p63 overexpression associates with poor prognosis in head and neck squamous cell carcinoma.
    Lo Muzio L, Santarelli A, Caltabiano R, Rubini C, Pieramici T, Trevisiol L, Carinci F, Leonardi R, De Lillo A, Lanzafame S, Bufo P, Piattelli A.
    Hum Pathol; 2005 Feb 01; 36(2):187-94. PubMed ID: 15754296
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Molecular analysis of surgical margins in head and neck squamous cell carcinoma patients.
    Nathan CO, Amirghahri N, Rice C, Abreo FW, Shi R, Stucker FJ.
    Laryngoscope; 2002 Dec 01; 112(12):2129-40. PubMed ID: 12461330
    [Abstract] [Full Text] [Related]

  • 34. [Prognostic and predictive value of koilocytosis, expression of e6 hpv types 16/18, p16ink4a, p53 in locally advanced squamous cell carcinomas of oral cavity and oropharynx, associated with human papillomavirus].
    Riaboshapka AN.
    Georgian Med News; 2014 Nov 01; (236):48-55. PubMed ID: 25541826
    [Abstract] [Full Text] [Related]

  • 35. Detection of minimal residual cancer to investigate why oral tumors recur despite seemingly adequate treatment.
    Partridge M, Li SR, Pateromichelakis S, Francis R, Phillips E, Huang XH, Tesfa-Selase F, Langdon JD.
    Clin Cancer Res; 2000 Jul 01; 6(7):2718-25. PubMed ID: 10914716
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Evaluation of p53 protein as a prognostic factor for oral cancer surgery.
    Cutilli T, Leocata P, Dolo V, Altobelli E.
    Br J Oral Maxillofac Surg; 2013 Dec 01; 51(8):922-7. PubMed ID: 23791033
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Twice-a-day radiotherapy for squamous cell carcinoma of the head and neck: the University of Florida experience.
    Parsons JT, Mendenhall WM, Stringer SP, Cassisi NJ, Million RR.
    Head Neck; 1993 Dec 01; 15(2):87-96. PubMed ID: 8440619
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 45.